Akero Therapeutics Inc (AKRO) Insider Trading
- $51,054,850.25
- $170,175,285.03
- Sept. 11, 2025
- Andrew Cheng
| Trader Name | Date | Title | Amount | Price | Type | Total Value | 
|---|---|---|---|---|---|---|
| Sept. 11, 2025 | Insider | 553 | $43.02 | Sell | $23,790.06 | |
| Sept. 11, 2025 | COO | 586 | $43.02 | Sell | $25,209.72 | |
| Sept. 11, 2025 | CEO | 1,796 | $43.02 | Sell | $77,263.92 | |
| Sept. 11, 2025 | CFO | 659 | $43.02 | Sell | $28,350.18 | |
| Sept. 11, 2025 | Insider | 659 | $43.02 | Sell | $28,350.18 | |
| Sept. 10, 2025 | CEO | 30,000 | $43.25 | Sell | $1,297,500.00 | |
| Sept. 8, 2025 | Insider | 12,500 | $44.17 | Sell | $552,125.00 | |
| Sept. 2, 2025 | COO | 12,500 | $46.08 | Sell | $576,000.00 | |
| Aug. 12, 2025 | COO | 12,500 | $47.79 | Sell | $597,375.00 | |
| Aug. 11, 2025 | CEO | 30,000 | $48.59 | Sell | $1,457,700.00 | |
| Aug. 5, 2025 | Insider | 12,500 | $49.30 | Sell | $616,250.00 | |
| July 16, 2025 | Insider | 10,000 | $52.95 | Sell | $529,500.00 | |
| July 10, 2025 | CEO | 30,000 | $51.16 | Sell | $1,534,800.00 | |
| July 7, 2025 | Insider | 12,500 | $51.09 | Sell | $638,625.00 | |
| July 1, 2025 | VP | 2,000 | $52.88 | Sell | $105,760.00 | |
| June 20, 2025 | VP | 875 | $54.59 | Sell | $47,766.25 | |
| June 18, 2025 | COO | 1,453 | $54.84 | Sell | $79,682.52 | |
| June 18, 2025 | CEO | 6,620 | $54.84 | Sell | $363,040.80 | |
| June 18, 2025 | CFO | 1,634 | $54.84 | Sell | $89,608.56 | |
| June 18, 2025 | Insider | 1,633 | $54.84 | Sell | $89,553.72 | |
| June 18, 2025 | CTO | 848 | $54.84 | Sell | $46,504.32 | |
| June 18, 2025 | Insider | 1,129 | $54.84 | Sell | $61,914.36 | |
| June 16, 2025 | VP | 2,000 | $54.14 | Sell | $108,280.00 | |
| June 16, 2025 | Insider | 10,000 | $54.23 | Sell | $542,300.00 | |
| June 10, 2025 | Insider | 2,358 | $54.00 | Sell | $127,332.00 | |
| June 10, 2025 | COO | 2,493 | $53.99 | Sell | $134,597.07 | |
| June 10, 2025 | CFO | 2,804 | $53.99 | Sell | $151,387.96 | |
| June 10, 2025 | Insider | 2,803 | $54.00 | Sell | $151,362.00 | |
| June 10, 2025 | VP | 919 | $54.00 | Sell | $49,626.00 | |
| June 10, 2025 | CEO | 37,837 | $54.05 | Sell | $2,045,089.85 | |
| June 6, 2025 | Insider | 25,000 | $55.04 | Sell | $1,376,000.00 | |
| June 5, 2025 | Insider | 12,500 | $53.49 | Sell | $668,625.00 | |
| June 2, 2025 | VP | 4,000 | $50.31 | Sell | $201,240.00 | |
| May 22, 2025 | VP | 4,000 | $50.00 | Sell | $200,000.00 | |
| May 15, 2025 | Insider | 10,000 | $39.30 | Sell | $393,000.00 | |
| May 12, 2025 | CEO | 30,000 | $41.48 | Sell | $1,244,400.00 | |
| May 7, 2025 | VP | 8,000 | $42.49 | Sell | $339,920.00 | |
| May 6, 2025 | Insider | 12,500 | $43.43 | Sell | $542,875.00 | |
| April 24, 2025 | Insider | 6,250 | $41.03 | Sell | $256,437.50 | |
| April 15, 2025 | Insider | 9,073 | $37.91 | Sell | $343,957.43 | |
| April 10, 2025 | CEO | 30,000 | $35.23 | Sell | $1,056,900.00 | |
| April 7, 2025 | Insider | 6,250 | $35.88 | Sell | $224,250.00 | |
| March 27, 2025 | Director | 50,000 | $43.55 | Buy | $2,177,500.00 | |
| March 25, 2025 | Director | 91,309 | $44.75 | Buy | $4,086,077.75 | |
| March 17, 2025 | Insider | 10,000 | $44.76 | Sell | $447,600.00 | |
| March 12, 2025 | COO | 607 | $44.88 | Sell | $27,242.16 | |
| March 12, 2025 | CFO | 676 | $44.88 | Sell | $30,338.88 | |
| March 12, 2025 | CEO | 1,738 | $44.88 | Sell | $78,001.44 | |
| March 12, 2025 | Insider | 614 | $44.88 | Sell | $27,556.32 | |
| March 10, 2025 | CEO | 30,000 | $41.77 | Sell | $1,253,100.00 | 
- Insiders are both buying and selling Akero Therapeutics Inc stock. 
- The insider traders at Akero Therapeutics Inc are: Andrew Cheng, Catriona Yale, Jonathan Young, William Richard White, Timothy Rolph, Patrick Lamy, G. Walmsley Graham, Seth Loring Harrison, Global Strategic Fund I Venbio, Kevin Bitterman, Scott A Gangloff, Skorpios Trust, Aaron Royston, Tomas J. Heyman, and Apple Tree Partners Iv, L.P. 
- The most active insider trader at Akero Therapeutics Inc is Andrew Cheng with 41 trades. 
- Skorpios Trust has sold the most Akero Therapeutics Inc stock with a total value of $142,332,000.00. 
- Apple Tree Partners Iv, L.P. has bought the most Akero Therapeutics Inc stock with a total value of $29,880,000.00. 
- The most recent insider trade for Akero Therapeutics Inc was on Sept. 11, 2025. 
- The single biggest insider buy for Akero Therapeutics Inc was from Apple Tree Partners Iv, L.P. with a total value of $14,940,000.00 on July 10, 2020. 
- The single biggest insider sell for Akero Therapeutics Inc was from Skorpios Trust with a total value of $71,166,000.00 on Dec. 1, 2022. 
